2024 to present, went down a rabbit hole of proxy documents from all the mergers and acquisitions in bioland after @daphnezohar tweet. To try to see if I can find any insights into what the turnaround period could be or what the outcomes may look like. I&I , Onco , rare disease

Daphne Zohar@daphnezoharFWIW hearing from M&A focused banks that there are multiple deals in the works and sounds like a couple of substantial ones could get announced in the near term (weeks). Will hopefully help with sentiment for biotech $XBI $BBC